| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8738386 | Immunology Letters | 2018 | 16 Pages |
Abstract
Our results demonstrated for the first time tumor inhibitory effect of mouse ROR1 specific antibody in a syngeneic mouse tumor model. This model is a promising tool for preclinical assessment of ROR1 therapeutics and investigation of the underling molecular mechanisms.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hadi Hassannia, Mohammad Mehdi Amiri, Farhad Jadidi-Niaragh, Reza Hosseini-Ghatar, Jalal Khoshnoodi, Ramezan-Ali Sharifian, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani, Fazel Shokri,